Clinical Trials in Baltimore

Showing 7281-7300 of 23,476 trials

Study of ATH434 in Participants with Multiple System Atrophy

NCT05109091

This study will assess the safety and efficacy of ATH434 in participants with Multiple System Atrophy

Alterity Therapeutics77 participantsStarted Jul 2022

La Jolla, California, United States • Chicago, Illinois, United States • Baltimore, Maryland, United States +20 more locations

COMPLETEDPhase 3< 1 mile

NEURO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

NCT04136184

The main objective of this study was to evaluate the efficacy of eplontersen as compared with the historical control of the placebo cohort in the NEURO-TTR trial (NCT01737398/2012-001831-30), in subjects with hereditary transthyretin-mediated amyloidosis polyneuropathy (hATTR-PN). For more information, please visit http://www.neuro-ttransform.com/.

Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

Ionis Pharmaceuticals, Inc.168 participantsStarted Dec 2019

Scottsdale, Arizona, United States • Jacksonville, Florida, United States • Indianapolis, Indiana, United States +42 more locations

Study of ATH434 in Participants with Multiple System Atrophy

NEURO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

Find Trials by Condition in Baltimore

Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients

Preventing Postpartum Depression in Immigrant Latinas

Ublituximab + TGR-1202 Compared to Obinutuzumab + Chlorambucil in Participants With Untreated and Previously Treated Chronic Lymphocytic Leukemia

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4144 Following Single and Multiple Ascending Doses Via Oral Administration to Healthy Participants

Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis

Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia

Skin Immunity Sample Collection Involving Blisters and Biopsies

Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy

Biomarkers to Predict Time to Plasma HIV RNA Rebound

Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of the Monoclonal Antibody PGT121.414.LS Administered Alone and in Combination With VRC07-523LS Via Intravenous or Subcutaneous Infusions in Healthy, HIV-uninfected Adult Participants

A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis

A Drug-drug Interaction Study of Avapritinib and Midazolam

Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer

Risk of Recurrent CeAD After Pregnancy

AAV Gene Therapy Study for Subjects with PKU

Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA)

An Age-Stratified Data Collection Study to Establish a Normative Database Using the 3D Optical Coherence Tomography 3D OCT-1000 Mark II

Nitrous Oxide for the Treatment of Major Depressive Disorder